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Abstract
In this chapter, the authors described the actuality of the investigations of neurocog-
nitive dysfunctions in patients with iron deficiency. In infants, the incidence of iron 
deficiency is 73%; the probability of its transition to iron deficiency anemia is very 
high. The development of myelin at an early age reduces the production of myelin, 
and the formation of g-aminobutyric acid worsens the metabolism of dopamine in the 
striatal brain, which leads to slowing of motor function and behavioral problems in 
the child. Children with iron deficiency conditions are prone to developmental delays, 
reduced school performance, and behavioral disorders. In older adults, cognitive dys-
functions depend on complications of the vascular nature, complicated by comorbid 
iron deficiency. Concomitant pathology also influences iron homeostasis. The regulat-
ing mechanisms of iron deficiency, as the same cognitive deficiency, despite the age 
involve more than 200 proteins from iron homeostasis, appropriate cofactors: deriva-
tives of vitamin B, copper, manganese, zinc ions, enzymes, cell growth factors, etc. 
All these partners could influence separately or together to the development of iron 
deficiency and a complication of it neurocognitive dysfunctions. The combination of 
iron deficiency anemia and iron deficiency with comorbid pathology often exacerbates 
cognitive problems and requires a weighted approach to the choice of therapeutic cor-
rection tactics.
Keywords: iron deficiency, neurocognitive dysfunction, comorbid pathology,  
iron homeostasis
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1. Introduction
Iron deficiency (ID) and iron deficiency anemia (IDA) could have multifocal pathologic effects 
[1–3]. However, one of the most socially significant consequences of ID is the burden to the 
cognitive abilities of the population [4–6]. At present, the prevalence of iron deficiency and 
iron deficiency anemia is 2–6% among European children. Given the importance of iron defi-
ciency relative to proper cognitive development and the alterations that can persist through 
adulthood because of this deficiency, the objective of this study was to review the current 
state of knowledge about this health problem [7]. In fact, there is a consensus that ID, without, 
concurrent anemia, has the same negative impact on cognition, behavior, and motor skills 
that can persist in the long-term [8]. So, the verification of ID in young age can be particularly 
important, because of the influence on the mental health and further cognitive functions dur-
ing the whole life of the people [9–11].
Neurophysiologic methodologies are noninvasive approaches that can provide information 
about the functional integration of the CNS [12, 13]. For example, dramatic decreases in laten-
cies in auditory and visual evoked potentials in infancy are often used to index the overall 
intactness and maturation of the CNS. Progressively, shorter latencies, until adult levels are 
achieved, are thought to reflect the increasing speed of transmission through sensory path-
ways, resulting in large part from increased myelination of the auditory and optic nerves and 
at the intracerebral level [14, 15].
Pathophysiological mechanisms of unfavorable impact on nervous system started in utero 
[16, 17]. The essential factors modifying the ID neurotoxicity are its depth and duration [18, 
19]. Evidence suggests that neonatal Fe status may be compromised as a consequence of 
maternal ID [20, 21]. Genes, infections, malnutrition, and other factors affecting fetal brain 
development are a major component of risk for a child’s emotional development and later 
mental illnesses, including schizophrenia, bipolar disorder, and autism [22–25]. As part of 
comprehensive maternal and fetal care, prenatal nutrient interventions should be further 
considered as uniquely effective first steps in decreasing risk for future mental illnesses and 
cognitive dysfunctions in newborn children [26–28]. Moreover, this fact makes the study of 
cognitive impairments in ID states especially urgent, because in recent years, the survival 
of preterm newborns has increased. Many of them have problems with iron deficiency. 
Every year in France, almost 35,000 babies (4–4.5%) are born at 35–36 weeks, 13,000 (1.5%) 
at 32–34 weeks, and 13,000 (1.5%) at less than 32 weeks (i.e., very preterm) [29]. In 2008, 
deliveries at 32–33, 34–36, and 37–38 weeks accounted for 1.2, 7.5, and 29.7%, respectively, of 
all births in the United States. Currently, depth preterm infants born at 32–33 weeks gestation 
and infants born at 34–36 weeks gestation make up the largest subgroup of preterm infants 
and contributors to more than 80% of premature births in the United States [30]. Multiple 
births currently account for nearly 3.5% of all births in the United States [31]. The health 
of neonates born to women carrying multiple fetuses is of concern, as this group alone is 
responsible for 15% of all preterm births and 20% of all low birth weight infants born in the 
United States [32]. More than 110,000 newborns in Russia are preterm [33].
IDA and ID often develop in children and adults with other diseases that lead to impaired cog-
nitive functions. Moreover, in such a situation, intellectual dysfunctions are formed because 
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of the action of several pathophysiological mechanisms. Feinstein in 1970 had introduced the 
concept of comorbidity, defining it as the presence of a separate additional clinical episode 
that exists or can manifest itself against the background of the current disease and always 
differs from it [34]. In addition, the introduction of perinatal factors, a number of concomitant 
diseases (comorbid diseases) occur in a person at different periods of his life [35, 36].
Obesity and ID are two of the most common nutritional disorders in the world. In children, 
both conditions deserve particular attention. ID and obesity have been independently asso-
ciated with poor cognitive function, but now the pathophysiological mechanism(s) linking 
obesity, ID, and cognitive dysfunction is unknown. Questions related to neuronal effects of 
insulin remain largely controversial. However, in the last decade, convincing evidence has 
been obtained that insulin and insulin-receptor signaling the brain system is necessary for 
normal functioning neurons [37]. Dysfunction of this system leads to the development of 
neurodegenerative diseases [38–40]. The interaction between ID and obesity in determining 
cognitive dysfunction could be driven by elevated hepcidin and reduced iron bioavailability 
in obese children. Pediatricians should bear in mind the potential effect of obesity-related ID 
on cognition in obese children and the need to evaluate both iron status and the presence of 
cognitive dysfunction [41, 42].
When considering the position of “iron as a victim” in obesity, emphasis is placed on mech-
anisms that cause sideropenia, as well as the accumulation of iron in adipose tissue. It is 
assumed that from this moment, the story “iron as a suspect” begins in the pathogenesis of 
obesity. There is a possibility of forming a vicious circle, in which ID, cumulating of iron in 
adipose tissue and direct obesity, is self-sustaining processes [43]. Several studies revealed an 
association between obesity and ID in children and, in some cases, a reduced response to oral 
supplementation of iron [44]. Randomized trials of low-dose iron supplementation (≤60 mg 
daily) for pregnant women are warranting testing the relationship between iron oxidative 
stress and insulin resistance/gestational diabetes, especially for iron-replete women. The con-
necting mechanism, however, is not completely known. This review is focused on the fol-
lowing: ID in obese children and the role of hepcidin in the connection between body fat and 
poor iron status; iron status and consequences on health, in particular on cognitive function; 
cognitive function and obesity; suggestion of a possible link between cognitive dysfunction 
and ID in pediatric obesity; and implications for therapy and future research [45].
There are a vast number of conditions affecting iron metabolism in all age groups [46–48].
Some of this leads to the appearance of ID, for example, with acute hemorrhage or chronic 
pathology. Recent studies addressing the physiological effects of poor iron status on physical 
performance, including work productivity, voluntary activity, and athletic performance in 
postmenopausal women are addressed. Similarly, the effects of iron status on neurological 
performance, including cognition, effect, and behavior, are observed [49]. Cognitive impair-
ment is common in elderly heart failure patients and is independently associated with anemia 
and renal dysfunction. Further studies are needed to assess whether optimal treatment of 
anemia and chronic kidney disease may prevent the development of cognitive impairment in 
heart failure patients [50].
ID was identified as a risk factor regarding the severity of several symptoms even without 
low hemoglobin level among chronic hemodialysis patients, and supplementation of iron was 
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considered efficacious for improving critical symptoms affecting those undergoing mainte-
nance dialysis [51].
Normally, timely recovery of the required number of red blood cells leads to rapid compensa-
tion of the patient’s condition, but adverse effects of IDA or ID could influence insufficient 
cognitive function in many acute and chronic diseases in adults [52].
The primary pathological mechanism of the concomitant diseases is hypoxemia of the brain 
tissue, stress-mediated vascular reactions, chronic inflammation in obesity, etc. [53–55]. 
Common causes of absolute ID in heart failure patients are drug interactions, poor dietary 
iron intake, gastrointestinal malabsorption, and gastrointestinal blood loss [56–59]. ID is a 
frequent comorbidity in preserved ejection fraction and is associated with reduced exercise 
capacity and quality of life. Its prevalence increases with increasing severity of diastolic 
dysfunction [60]. Anemia in elderly patients with concomitant atherosclerosis and arterial 
hypotension is a significant risk factor for transient ischemic attacks and ischemic stroke, and 
diabetes is the adverse impact for cognitive abilities. IDA and subcortical ischemic change 
might be associated with increased risks for cognitive impairment among the elderly [61, 62].
At the current stages of science, many problems of synergy between ID and comorbid dis-
eases for cognitive functions in patients have not been resolved, which makes it challenging 
to choose effective therapy.
2. Neurocognitive dysfunctions
The Latin term “cognitio”—the functioning of human cognition, more precisely, is the abil-
ity to understand the ongoing process. Tolman first proposed the formulation in 1948 [63]. 
Cognition began to be studied not only in philosophy but also in the specific sciences—psy-
chology, physiology, medicine, pedagogy, etc. [64, 65]. Cognitive functions are perception, 
ingenuity, the ability to get acquainted with new information and memorize it, attention, 
speech, orientation in space and time, and motor skills. In children with ID, cognitive impair-
ments lead to a delay in intellectual development, difficulties in educating. Based on the fact 
that neurons are the morphological substratum for cognitive functions, scientists often use the 
term neurocognitive. However, the most base evidence data were achieved in children popu-
lation. The initial status of children could be determined by the results of complex clinical and 
psychological diagnosis, which are aimed at assessing the cognitive and motor spheres. The 
panels of the tests to diagnose the neurocognitive and motor dysfunctions in children and 
adults include numerous tests, widely used in current medicine [66, 67].
Examples of the tests to diagnose neurocognitive dysfunctions:
1. Visual selective reminding TOMAL samples of various domains of memory in children 
and adolescents, ages 5 years 0 months through 19 years 11 months, 30 days. The TOMAL 
is composed of a core battery of 10 subtests, including 5 verbal and 5 nonverbal subtests, as 
well as supplementary subtests (3 verbal and 1 nonverbal). Four TOMAL subtests assess 
retrieval both immediately upon stimulus presentation and following a 30-min filled 
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delay. Among the 10 core subtests, memory for stories involves immediate and delayed 
free recall of short verbal narratives and word selective reminding is a verbal list learning 
task that includes a delayed free recall condition [68].
2. First proposed by Swiss psychologist André Rey in 1941 and further standardized by Paul-
Alexandre Osterrieth in 1944, it is frequently used to further explain any secondary effect 
of brain injury in neurological patients, to test for the presence of dementia, or to study 
the degree of cognitive development in children. Thе “Rey– Alexander Osterrieth complex 
figure test” (ROCF) is a neuropsychological assessment in which examinees are asking 
to reproduce a complicated line drawing, on the first copy it freehand (recognition), and 
then drawing from memory (recall) [69]. Many different cognitive abilities are needed for 
a correct performance, and the test, therefore, permits the evaluation of different functions, 
such as visuospatial abilities, memory, attention, planning, and working memory (execu-
tive functions) [70].
3. Verbal fluency tests are semantic verbal fluency tests with the categories Animals and Fruit 
and could be used for lexical/phonemic ability versions due to the educational heterogene-
ity of the local population, which sometimes limits the use of instruments that require 
knowledge acquired through higher formal education [71].
4. Visual-motor integration is using the Beery-Buktenica Developmental Test of Visual-Motor 
Integration (Beery VMI) (Beery, 1989; Beery, 1996; Beery and Beery, 2004). The Beery VMI 
is comprised of drawings of geometric forms that increase in difficulty. The forms are 
copied with paper and pencil and scored based on objective scoring criteria outlined in 
the test manuals according to how accurately they were copied when compared to the 
original. The Beery VMI has been demonstrating good reliability and validity as reported 
in the manual [72, 73].
5. The “Bruninx-Ozeretskii test” was estimate using for motor function of the person. The 
child is asked to perform a series of game tasks available for understanding children from 
4 years. The person is given a clear instruction describing the nature of the task, and then 
the researcher shows the child an image on the cardboard a card showing a child perform-
ing the same task. With difficulties in perception of the patient information, the researcher, 
as an example, performs the task itself and then invites the child to repeat it. The result is 
integrated into the indicator “General motor rating”, presenting in the form of a percentile 
scale with the maximum and minimum values from 20 to 80. The Achenbach System of 
Empirically Based Assessment, created by Thomas Achenbach [74, 75], is a collection of 
questionnaires used to assess adaptive and maladaptive behavior and overall function-
ing in individuals. The system includes report forms for multiple informants—the Child 
Behavior Checklist is used for caregivers to fill out ratings of their child’s behavior; the 
Youth Self Report Form (YSR) is used for children to rate their own behavior; and the 
Teacher Report Form is used for teachers to rate their pupil’s behavior. The ASEBA seeks 
to capture consistencies or variations in behavior across different situations and with dif-
ferent interaction partners [76].
6. IntegNeuroTM is standardized and semiautomated computerized battery assesses sen-
sorimotor function, attention, new learning and memory, language fluency, executive 
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function, and estimated intelligence. A total of 50 healthy individuals were included in the 
study. Correlational analyses revealed highly significant associations between the two cog-
nitive batteries. These results support the use of IntegNeuroTM as a computerized cogni-
tive system. Additional studies are needed to examine the clinical utility of the battery [77].
This tests and/or other could be used not only at the baseline but also for monitoring neuro-
cognitive dysfunctions.
3. Iron deficiency and nervous system
The concentration of iron in the brain reaches 21.3 mg per 100 mg, whereas in the liver—
only 13.4 mg per 100 mg. Iron serves as a critical cofactor for proteins involved in a host of 
biological processes. Iron is of central importance to many vital processes because the metal 
is a catalytic component of crucial metabolic enzymes in the citric acid cycle, mitochondrial 
respiration, replication, or neurotransmitter synthesis [78]. Synapse growth is examined spe-
cifically in conditions of iron deficiency in the Drosophila. It is shown that projections of 
the small ventrolateral clock neurons to the protocerebrum of the adult Drosophila brain are 
significantly reduced upon chelation of iron from the diet. This growth defect persists even 
when iron is restored to the diet. Genetic neuronal knockdown of ferritin 1 or ferritin 2, criti-
cal components of iron storage and transport, does not affect synapse growth in these cells. 
Together, these data indicate that dietary iron is necessary for central brain synapse formation 
in the fly and further validate the use of this model to study the function of iron homeostasis 
on brain development [79–81].
In the monkey model, scientists show that both during and after a period of ID, iron-dependent 
neural processes are affected, which raises the potential concern that the anemia commonly 
experienced by many growing infants that could have a protracted effect on the developing 
brain. To further investigate the effects of ID on the immature brain, 49 infant rhesus monkeys 
were evaluated across the first year of life. The mothers, and subsequently the infants after 
weaning, were maintained on a standardized diet containing 180 mg/kg of iron and were not 
provided other iron-rich foods as treats or supplements. As the infants grew, they were all 
screened with hematological tests, which documented that 16 (33.3%) became markedly ID 
between 4 and 8 months of age. During this anemic period and subsequently at 1 year of age, 
cerebrospinal fluid (CSF) specimens were collected to compare monoamine activity in the ID 
and iron-sufficient infants. Monoamine neurotransmitters and metabolite levels were normal 
at 4 and 8 months of age, but by 1 year, the formerly anemic monkeys had significantly lower 
dopamine and significantly higher norepinephrine levels. These findings indicate that ID can 
affect the developmental trajectory of these two important neurotransmitter systems, which 
are associated with emotionality and behavioral performance, and further that the impact on 
the young monkey was most evident during the period of recovery [82].
ID in the first year of life can have a negative impact on the processes of postnatal central ner-
vous system (CNS) formation, which can have long-term consequences for the development 
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of the child [83]. Several decades ago, it was believed that new brain cells in an adult are not 
formed. That person can study only up to 25 years, and then the brain has lost the chance to 
be educated. Those intellectual abilities are inherited or inherent in quality, and they cannot 
be developed during the life. Now we know that this is not so. The human brain develops all 
his life (Figure 1). In the world literature, the influence of ID and IDA on the functioning of the 
human and animal organism, including on the nervous system is discussed [81, 84].
By the time of birth, the baby’s brain is immature. Nevertheless, with each month the child 
learns more and more. To make the signals go quickly and in the right direction, the nerve 
fibers in an adult person are isolated. Just like electrical wires. A substance that performs the 
role of isolation is called a myelin or myelin sheath. Nerve cells maintain a connection with 
each other with the help of processes, which are called dendrites and axons or nerve fibers 
[85, 86]. Signals on these fibers almost instantly move from cell to cell. It is like how electricity 
flows through the wires (Figure 2). Genes control myelination. To activate them, the cells of 
the brain need iron. ID inhibits myelination, as it does not allow cells to maintain high activity 
of these genes. Therefore, children with ID can develop hyperactivity and lack of attention in 
the future. From the fact that myelin is in lack, the nervous system will not learn to isolate and 
direct the signals well [87].
Figure 1. Growth cone of axon (https://www.turkaramamotoru.com/ru/).
Figure 2. Location of myelin sheath in neuron (https://www.goconqr.com/en-US/p/615525).
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Iron homeostasis impairment is also a component of peripheral neuropathies [88]. The main 
function of the peripheral nervous system (PNS) is to collect impulses from the periphery and 
transfer them to the CNS, where they are integrated to generate an adequate response. PNS 
neurons extend over a significant length that in humans can reach above 1 m in extension [89]. 
Thus, a correct and fast conduction of electrical impulses is essential for rapid and maximal 
response. In vertebrates, this is achieved by the generation of myelin [90]. Besides providing 
axonal insulation, several evidences indicate that myelin is essential also for neuronal protec-
tion. In the absence of myelin, axons degenerate, and this is the main cause of morbidity in 
demyelinating and demyelinating disorders. The homeostasis of iron in the PNS influence, on 
its transport across the blood-nerve barrier, its involvement in myelination [16].
Restless legs syndrome is one of the examples of peripheral neuropathies. The pathophysiol-
ogy of idiopathic restless legs syndrome is still incompletely understood; however, it is well 
established that disturbances of dopaminergic function and alterations of iron homeostasis 
are involved in its pathogenesis [91–93]. Concerning iron metabolism, the general hypothesis 
is that iron deficiency is common in RLS patients, as reflected by reduced iron levels in brain 
sections, measurements of decreased iron levels in the cerebrospinal fluid, and imaging stud-
ies indicating iron dyshomeostasis in the brain [94].
The quality and quantity of sleep are increasingly recognized as important factors in human 
development, with concomitant effects on affective behavior and cognitive performance [95]. 
In addition to biological mechanisms, cultural factors are also important determinants of sleep 
practices and behaviors in infants, children, and adolescents, and influence both the type and 
frequency of sleep problems found in the pediatric population [96]. IDA in infancy is associated 
with long-lasting neurofunctional effects despite iron treatment; the normal development of 
sleep patterns might be affecting. Night polysomnographic recordings were performed in 55 
healthy 4-year-old children (former IDA = 27 and nonanemic controls = 28). Both groups were 
followed from infancy and were similar in background characteristics. The duration of each 
waking episode was measured, as was the duration of each episode of no rapid eye movement 
(NREM) sleep stages 1 (NREM1), 2 (NREM2), and 3–4 (SWS), and rapid eye movement (REM) 
sleep. The data were analyzed according to the successive thirds of the total sleep time (TST). 
Relative to controls, former IDA children showed: (a) longer duration of REM sleep episodes 
in the first third and shorter in the last third, (b) more REM sleep episodes in the first third and 
fewer in the second third, and (c) shorter latency to the first REM sleep episode and shorter 
NREM stage 2 and SWS episodes within the first sleep cycle. The results show that early IDA is 
associated with long-lasting alterations in the temporal organization of sleep patterns [97, 98].
The work reveals CNS developmental delay through the study of qEEG (less rapid and 
slower frequencies) which recovered significantly with iron supplementation. It is concluded 
that IDA constitutes a high risk factor for a lag of CNS maturation [99]. Neuroscientists who 
use MRI in a special functional mode also found activation of whole areas of the brain dur-
ing their use. And they also saw “holes” in the activity of the brain, in those people, which 
lead an unhealthy lifestyle or get micronutrients: iron, other trace elements, and vitamins 
[94]. Genes also control neuroplasticity. Iron is necessary for their activation. Fetal-neonatal 
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iron deficiency dysregulated genes important for hippocampal development both acutely and 
persistently into early adulthood [100, 101]. A number of studies have shown that cognitive 
functions, especially memory in women with iron deficiency, are reduced compared with 
their peers without deficiency. In other words, their brains do not have enough resources to 
train. However, unlike myelination, active neuroplasticity is not limited in time, but occurs 
throughout life [102].
The rate of development of the nervous system of the child also slows down with ID [103]. 
For complex skills, extensive neural networks are needed. To have neural networks, myelin 
is needed. If it is not enough, new skills are late. This is most noticeable in speech. Children 
with latent ID or anemia in their first year of life usually start talking later. Evoked potentials 
provide noninvasive measures of nerve transmission and CNS functioning. Auditory brain-
stem responses and visual evoked potentials show dramatic changes in infancy, largely as a 
result of progressive myelination. Because iron is required for normal myelination, pathway 
transmission in these sensory systems is affected by early iron deficiency. Absolute latencies 
for all auditory brainstem responses and visual evoked were significantly longer in former 
IDA children [104, 105].
Some studies have established that cognitive impairment may be closely associated with 
neuroanatomical damage and zinc metabolism in the hippocampus due to iron deficiency, 
which may result from abnormal cholinergic function. The hippocampus is the focus of many 
studies today, since this brain structure has high zinc concentration and is highly involved in 
many forms of cognitive deficits as a consequence of cholinergic deficiency and has achieved 
prominence because of dementia in aging and Alzheimer’s disease [106]. Thus, it is now 
apparent that cognitive impairment may not be attributed to a single neurotransmitter, but 
rather, alterations and interactions of several systems in different brain regions. In animal 
models of iron deficiency, it is apparent that dopaminergic interaction with the opiate system 
and cholinergic neurotransmission may be defective [107].
Figure 3. The location of hippocampus (http://www.thinglink.com/scene/834791711828869120).
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Memory can also suffer from lack of iron in early childhood. The hippocampus is the region 
of the brain responsible for memory. It forms, stores, and reproduces the knowledge and 
experience of a person. The quality of memory and the speed of reproduction depend on the 
development of neural networks of the hippocampus. The main parts of the brain involved 
with memory are the amygdala, the hippocampus, the cerebellum, and the prefrontal cortex 
(Figure 3).
Studying the effect of iron deficiency on the hippocampus of laboratory animals, scientists 
discovered an interesting fact. In rats suffering from iron deficiency in utero, the hippocam-
pus at birth is less in volume than in their peers, with which the gland lacked. Moreover, these 
changes persist when rats grow [108, 109]. It is assumed that the human iron deficiency affects 
the hippocampus in a similar way [110]. In addition, it is assumed that changes in dopamine 
metabolism in the brain occur in response to ID, as well as altered serotonergic neurotrans-
mission and dopamine receptor function [7, 111].
Chronic ID during development, independent of anemia, alters the adult mouse hippocampal 
transcriptome. Restoring iron status during a known critical period of hippocampal neurode-
velopment incompletely normalized these changes, suggesting a need for additional studies 
to identify the most effective timeline for iron therapy and adjunctive treatments that can fully 
restore ID-induced molecular changes, particularly in human populations in whom chronic 
ID is endemic [112].
The problem of attention deficit hyperactivity disorder (ADHD) is actually everywhere. 
Different international groups confirmed the correlation of iron serum parameters, serum 
ferritin, and ADHD. Indian pediatricians with a high level of significant found that serum 
ferritin level was significantly lower among ADHD patients. This finding is consistent with 
multiple previous studies [113, 114]. Many other studies reported an association between iron 
deficiency and ADHD [115, 116].
Based on the stroke registry at the Hospital for Sick Children (Toronto, Ontario, Canada), 
physicians found that comparatively previously healthy children with stroke were 10 times 
more likely to have IDA than healthy children without stroke. Furthermore, children with 
iron deficiency anemia accounted for more than half of all stroke cases in children without 
an underlying medical illness, which suggests that iron deficiency anemia is a significant risk 
factor for stroke in otherwise healthy young children. Primary prevention and early identifi-
cation of iron deficiency anemia must remain a priority [117].
4. Iron deficiency and cognition
In fact, patients with chronic ID are presented with lower grades in the language, perception of 
ambient sound, and motor measures compared with children with normal dietary iron status 
[118, 119]. Moreover, Lozoff et al., the most productive researcher of this term, reported that 
changes in the mesolimbic pathway, positive influence, and inherent reward could support 
the explanation of the altered social-emotional behavior described in children with ID. Thus, 
the status of iron appears to be the decisive determinant of cognitive functioning in children, 
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and its destruction implies significant consequences for the health of the child. Improvement 
of iron status in 12-months and 6-years children has diminished the public health threat asso-
ciated with iron depletion in the population studied [120]. Therefore, actions to prevent iron 
depletion in infancy remains are very important [121, 122].
The infant period of life with ID dramatically influence at the intellectual functions. Iron 
deficiency in first year of life occurs at a time point of rapid neural development and when 
morphological, biochemical, and bioenergetics alterations take place. The structures of the 
brain can either become abnormal because of ID in utero or in early postnatal life because iron 
is essential for proper neurogenesis and differentiation of certain brain cells and brain regions 
[123, 124]. Early ID alters the transcriptome, metabolome, structure, intracellular signaling 
pathways, and electrophysiology of the developing hippocampus, the brain region respon-
sible for recognition learning and memory. Until recently, it was unclear whether these effects 
are directly due to lack of iron interacting with important transcriptional, translational, or 
post-translational processes or to indirect effects such as hypoxia due to anemia or stress [125].
Data indicate poorer object permanence and short-term memory encoding and/or retrieval in 
infants with IDA at 9 months. These cognitive effects were attributable, in part, to IDA-related 
deficits in socioemotional function. Children with poor socioemotional performance seem to 
be more vulnerable to the effects of IDA on cognitive function IDA [126, 127]. Improved iron 
status at 12 months and 6 years has diminished the public health threat associated with iron 
depletion in the population studied [128].
Several previous studies have shown that children with low levels of iron in their blood do 
worse than those who without ID on tests that measure cognitive skills, such as thinking, learn-
ing, and memory, according to the background information in the article [129]. Researches from 
the University of Michigan studied the long-term effects of ID and socioeconomic status in a 
group of 185 children from an urban area in Costa Rica. The children, who were an average 
of 17 months old when the study began in 1983–1985, were screened for ID at their first visit. 
They were given cognitive tests (on which the index, or overall average score, is 100) then and 
again at ages 5, 11–14, 15–18, and 19 years. Those who had low iron levels in infancy even after 
3 months of iron therapy were compared with those who had normal iron levels either without 
or after treatment. The gap in cognitive scores between iron-deficient and non-ID teens had 
widened to 25 points (70.4 vs. 95.3). “The observed pattern appears to make sense in terms of 
the cumulative and transactional nature of cognitive development.” Acquisition of new skills 
is intimately linked to mastery of skills at an earlier developmental level. If direct and indirect 
effects of early ID on the brain disrupted or delayed basic developmental processes, there could 
be a snowball effect. In an economically stressed family environment, there might not be the 
resources or capacity to help children compensate. The authors conclude that the results high-
light the necessity to identify the children at risk for ID and prevent or treat the condition in 
infancy [130].
Rates of ID are high among healthy young women. Cognitive impairment occurs secondary 
to ID in infants and children, but evaluation of the impact on cognition among young women 
is inconsistent. The aim of the research was to determine the suitability of the IntegNeuro 
test battery for assessing cognitive function in ID and iron-sufficient young women. A pilot 
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double-blinded, placebo-controlled intervention trial was conducted in iron-deficient (serum 
ferritin ≤20 μg/L and hemoglobin >120 g/L) and iron-sufficient young women (18–35 years). 
Cognitive function and hematological markers of iron status were measured at baseline and 
follow-up. Iron-deficient participants (n = 24) were randomized to receive placebo, 60 or 
80 mg elemental iron daily supplements for 16 weeks. A control group of iron-sufficient par-
ticipants (n = 8) was allocated to placebo. Change scores for impulsivity and attention were 
significantly greater in plasma ferritin improvers than in nonimprovers (p = 0.004, p = 0.026). 
IntegNeuro was easy to administer and acceptable to young women. Based on the differences 
in memory and attention scores between iron-deficient participants on iron treatment and 
those on placebo, it was decided that between 26 and 84 participants would be required in 
each iron treatment group for an adequately powered extension of this pilot study [131].
In Archangelsk, Russia ID without iron deficiency anemia was diagnosed in 46.7% of the 
children among 90 children aged 7–8 years attending comprehensive schools. Contingency of 
Toulouse-Piéron test results with the level of serum iron was evaluated by means of Pearson 
χ2-test, the effect being determined by “phi” coefficient. Statistically significant association 
was detected between the level of serum iron and AIP of Toulouse-Piéron test (χ2 = 21.878 and 
p = 0.039) with a relatively strong effect (φ = 0.493). The study has shown that ID without IDA 
has a negative effect on the accuracy of information processing [132].
ID and, in an even greater degree, IDA affects the formation of such a complex psychosocial 
effect as social isolation [133]. The consequences of this phenomenon during schooling can 
restrain the realization of the child’s cognitive abilities. Children who are iron deficient (ID) or 
iron-deficient anemic (IDA) have been shown to seek and receive less stimulation from their 
caregivers, contributing to functional isolation. Over time, the reduced interactions between 
child and caregiver are thought to interfere with the acquisition of normative social compe-
tencies and adversely affect the child’s development [31].
5. Deficiency of iron in patients with imbalance of micronutrients
Numerous vitamins, macro- and microelements, indispensable components, and nutrition 
of a person represent the value of the micronutrient complex, since they are necessary for 
the occurrence of numerous biochemical reactions in the body, including ensuring human 
intellectual abilities. Micronutrients are chemically and physiologically active substances that 
are able to interact with other substances, as well as with each other. These interactions can 
lead to an increase or decrease in the effect of taking vitamin-mineral complexes. For example, 
calcium and zinc reduce the absorption of iron. Moreover, the addition of vitamins A, C, and 
others—strengthen, contributing to the correction of IDA and ID.
A frequent cause of neurocognitive impairment is a mono or poly-micronutrient deficiency. 
The micronutrient deficiency mostly delivers during pregnancy [134, 135]. For an example 
widespread iron deficiency, iodine deficiency is a monodeficiency, that is, are due to a lack 
of only one element. Iron is the most abundant transition metal in biology and an essen-
tial cofactor for many cellular enzymes. The literature on the effects of micronutrients on 
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cognitive, motor, and behavioral development is reviewed focusing mainly on children. Iron, 
zinc, iodine, and vitamins are discussed. The review is selective and concentrates on the more 
recent work and areas of controversy. There are well-established associations with poor devel-
opment and iron and iodine deficiencies but the deficiencies usually occur in disadvantaged 
circumstances, and establishing causal relationships is difficult [136]. More than 200 proteins 
of iron homeostasis cannot function without corresponding cofactors: derivatives of group 
B vitamins, copper ions, manganese, zinc, etc. [137, 138]. For example, 9 copper-containing 
enzymes and 22 manganese-dependent proteins are involved in the homeostasis of iron.
In addition to iron, microelements such as copper and cobalt, to a lesser extent manganese, 
zinc, etc., play an important role in the processes of normal development of nervous system. 
According to the National Nutrition Monitoring Bureau of India, IDA is diagnosed in many 
healthy children, and two-thirds have clinical symptoms of ID combined with a deficiency of 
essential trace elements such as iodine, zinc, copper, etc. [139]. Hypermanganesemia in chil-
dren with SLC39A14 gene mutation (OMIM 608736 8p21.3) is associated with severe ID [140].
Copper is an immediate participant in the transfer of elemental iron to the bone marrow 
and the formation of mature forms of erythrocytes from their precursors—reticulocytes; it 
promotes the utilization of iron for the formation of hemoglobin molecules. Physiological 
variables of iron and copper are related to each other [141]. One of the key enzymes of the 
“respiratory chain” of electron transfer is cytochrome C oxidase, containing a copper and iron 
ion as cofactors. Therefore, copper can be considered one of the main synergists of iron [142].
Fe(II) and Cu(II) act synergistically to delay anaerobic growth of bacteria environmentally 
relevant metal concentrations [143]. The lack of copper also leads to the exhaustion of the 
nervous system. The deficiency in the activity of Cu, Zn-superoxide dismutase due to genetic 
defects, and deficiencies in zinc or copper leads to amyotrophic lateral sclerosis, a neurode-
generative disease of motor neurons. In addition to influence the processes of inflammation, 
the activity of superoxide dismutase affects the hemolysis of erythrocytes and the cellular 
homeostasis of iron [144]. There are other works determining the place of combined trace 
elements in the pathogenesis of neurodegenerative diseases [145].
Supplementation studies in infants and elder children revealed that zinc might also play a 
major role in brain function based on strong evidence from experimental animals. Zinc defi-
ciency gestation in mice, rats, and rhesus monkeys caused impaired learning, reduced atten-
tion, and poor memory in their offspring. There is lack of data in humans and inconclusive. 
With respect to brain function alone, other nutrients such as docosahexaenoic acid (DHA, 22:6 
n-3 fatty acid) improve visual acuity and mental development in small-for-gestational-age 
infants, folate supplementation during pregnancy prevents neural tube defect in infants, and 
selenium deficiency in animals affects activities of brain enzymes necessary for brain develop-
ment and function [146, 147]. Critical issues to be considered include: single versus multiple 
limiting nutrients, critical period of deficiency, responsive indicators and variables that may 
affect the results as environmental, and psychological and social factors [148, 149].
Studies of trace element deficiency in the children’s population of the Chelyabinsk region, 
carried out in 2014, confirmed the widespread occurrence of ID conditions. More than 40% 
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of adolescents aged 13–15 years had misbalances of essential trace elements. The most often 
deficiency of iron was associated with lack of copper, zinc, chromium, phosphorus, and 
magnesium. Deficiency of iron was more pronouncing against the background of increased 
content of heavy metals in biosubstrates: hair and blood of the adolescents surveyed [150].
Vitamin D deficiency was also associated with moderate anemia among young children. The 
role of vitamin D, vitamin B-12, and folic acid in risk for anemia in multi-nutrient deficiency 
responsible for cognitive development needs to be examined in further studies [151–154].
5.1. The role of erythropoietin in cognitive dysfunctions
Since 1906, thanks to the pioneering work of French scientists, R. Carnot and S. Deflandre, 
erythropoietin (EPO) has become known primarily as a hemopoietin factor stimulating the 
formation of red blood cells de novo. They found that after bleeding a rabbit, there was, in its 
serum 24 h later, some factor which stimulated red cell production in normal rabbits. They 
called it hemopoietin, but it was later called erythropoietin [155].
EPO (Figure 4) is an important renal hormone, and the secretion of which is regulated by 
such factors as the blood supply of the kidneys, the level of iron in the blood plasma, the 
cross hormonal effects from the sympathetic nervous system, and endocrine glands [50, 156]. 
Recently, it became known that EPO, in spite of its name, is important not only for the regula-
tion of erythropoiesis but also for the regulation of the growth and multiplication of cells of a 
number of other tissues, including, importantly, the cells of the nervous system. Thus, EPO is 
an important growth factor for neurons [157, 158].
The authors demonstrate with the animal model that EPO would diminish the deleterious 
effects of a social stressor in mice. Indeed, EPO induced anxiolytic and antidepressant-like 
responses in a forced swim test, open field, elevated-plus maze, and a novelty test and 
appeared to blunt some of the negative behavioral effects of a social stressor. Furthermore, 
EPO promoted adult hippocampal neurogenesis, an important feature of effective antidepres-
sants. The EPO could be recommended as a possible adjunct treatment for affective disorders, 
as well as other stressor-associated disorders of impaired neuroplasticity [159, 160].
Figure 4. The structure of the erythropoietin molecule (http://en.turkcewiki.org/wiki/Erythropoiesis-stimulating_agent).
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EPO, which is widely prescribed to treat anemia, has recently emerged as a potent neuro-
trophic factor with robust actions on the brain. A slight decrease in the level of EPO is also 
observed in patients with depressed states not suffering from chronic renal failure, in part 
because, as it turned out in recent years, the brain is also one of the places of EPO secretion, 
where it plays the role of a neuropeptide. EPO receptors are found in areas of the brain impor-
tant for cognitive functioning, such as the hippocampus and the prefrontal cortex. One of the 
important reasons for the development of depression and cognitive impairment in chronic 
renal failure patients is the reduction in the secretion of EPO by the kidneys. The introduction 
of recombinant human EPO in patients with CRF improves their overall well-being, cogni-
tive function and reduces the level of depression regardless of the effectiveness of treatment 
with erythropoietin anemia [161]. It has been shown that the administration of recombinant 
human EPO-alpha or beta has an antidepressant effect and improves the cognitive function of 
patients with depression, even those who do not suffer from renal failure [162, 163]. It is also 
interesting to note that the most effective antidepressant treatment/electroconvulsive therapy 
is accompanied by a marked increase in the secretion of EPO by brain tissue. It has also been 
shown that the additional administration of exogenous EPO can not only enhance the antide-
pressant effect of electroconvulsive therapy but also reduce the cognitive impairment caused 
by electroconvulsive therapy [164, 165].
In one of the first prospectively designed studies IDA, evaluation of the better neurocogni-
tive outcomes was found of preterm infants randomized to receive Darbepoetin (Darbe) in 
compared with placebo. Preterm infants had significantly higher cognitive scores compared 
with the placebo group. Authors reported decreased transfusions and donor exposures in pre-
term infants randomized to Darbe or EPO compared with placebo. As these erythropoiesis-
stimulating agents (ESA) have shown promise as neuroprotective agents. Of the original 102 
infants (946 ± 196 g and 27.7 ± 1.8 weeks’ gestation), 80 (29 EPO, 27 Darbe, and 24 placebo) 
returned for follow-up. The three groups were comparable for age at testing, birth weight, and 
gestational age. After adjustment for gender, the analysis of covariance revealed significantly 
higher cognitive scores among Darbe (96.2 ± 7.3; mean ± SD) and EPO recipients (97.9 ± 14.3) 
compared with placebo recipients (88.7 ± 13.5; P = .01 vs. ESA recipients) as was object perma-
nence (P = .05). No ESA recipients had cerebral palsy, compared with five in the placebo group 
(P < 0.001). No differences among groups were found in visual or hearing impairment. In the 
conclusion, infants randomized to receive ESA had better cognitive outcomes, compared with 
placebo recipients, at 18–22 months. Darbe and EPO may prove beneficial in improving long-
term cognitive outcomes of preterm infants [166].
The possibility of clinical use of drugs, recombinant EPO to protect the brain, presents 
the main currently known mechanisms for the implementation of its neuroprotective 
potential, not connected with the influence on erythropoiesis. Several preclinical and 
clinical studies have demonstrated that systemic administration of EPO is sufficient to 
produce behavioral effects. Clinical trials have reported striking improvement in cogni-
tive function in schizophrenia patients and treatment resistant depression. EPO has been 
shown to improve cognitive function in schizophrenia and treatment resistant depressed 
patients [162].
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However, the potent elevation of red blood cell counts by EPO can cause hematological com-
plications in nonanemic patients. The conducted mass-spectrometry-based peptide mapping 
of carbamoylated Epo (Cepo) tested its ability to improve cognitive function after social defeat 
stress. Gene expression analysis in discrete brain regions was performed to obtain mecha-
nistic insight of Cepo action. Cepo reversed stress-induced spatial working memory deficits 
while affecting long-term (24 h) novel object recognition in these rats. Contextual fear condi-
tioning following defeat was enhanced by Cepo, but attenuated in controls. However, Cepo 
improved fear extinction in all rats compared to vehicle treatment. Cepo induced differential 
gene expression of VGF and neuritin in the mPFC and discrete hippocampal subfields, with 
strongest induction in the dorsal hippocampus. Analysis of gene-brain region-behavior inter-
actions showed that Cepo-induced neurotrophic mechanisms influence cognitive function. 
Carbamoylated EPO can be developed as a therapeutic neurotrophic agent to treat cogni-
tive dysfunction in neuropsychiatric diseases. Due to its distinct mechanism of action, it is 
unlikely to cross react with the activity of currently prescribed small molecule drugs and can 
be used as an add-on biologic drug [167].
The use of EPO in preterm infants both for anemia treatment and correction of immunological 
and neurological status is considered a prospective direction, but it is complicated by the lack 
or inconsistency of data on the concentration of endogenous EPO in serum. The concentration 
of serum EPO in preterm infants with a gestational age of 27–36 weeks and 6 days (Apgar 
scores 4.32 points) was higher by 1 day after birth and did not differ from a group of full-term 
infants on 10th day. In preterm infants with gestational age 27–31 weeks and 6 days (Apgar 
score 3.33), the concentration of serum EPO is higher by 1 day and is lower by 10th day after 
birth. In preterm infants with gestational age 32–36 weeks and 6 days (Apgar score 5.5), the 
concentration of serum EPO was lower on 1st day after the birth, and it did not differ from 
indices in the group of full-term infants on 10th day. The concentration of serum EPO in 
preterm infants with 27–31 weeks 6 days of gestation increases on the 1st, decreases on 10th 
day after birth as gestational age decreasing, and the total Apgar score reduces [168].
Pro-cognitive effects of EPO occurred across affective disorders. Neuropsychological screen-
ing for cognitive dysfunction may be warranted in future cognition trials.
6. Discussion and conclusions
About one-fifth to one-fourth of children around the world has IDA, in which lack of iron 
causes problems with hemoglobin—the compound that red blood cells used to transport 
oxygen through the bloodstream. Many more have low iron without anemia. Children from 
poor, minority, or immigrant backgrounds are more likely to be ID. ID is associated with 
alterations in many metabolic processes that may impact brain functioning (e.g., mitochon-
dria electron transport, neurotransmitter synthesis and degradation, protein synthesis, and 
organogenesis).
Although IDA and ID without anemia may be associated with poor cognitive/behavioral 
outcomes, this has not been sufficiently studied. In particular, there is lack of dose response 
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studies linking indicators of iron status as continuous risk factors with later cognitive out-
comes. The lack of effect in the youngest infants may be because of irreversible effects of ID 
on the developing brain or the fact that cognitive development and behavior are more difficult 
to measure in young children [47]. IDA has been consistently linking to altered child affect, 
energy, and activity, but little knows about how these aberrations affect later development or 
adjustment in other contexts.
Summarizing the data presented in probably formulates effector mechanisms of influence on 
the implementation of the ID neurocognitive skills in children and adults:
• hypoxia, tissue hypoxemia
• the enzymatic deficiency in organs of the nervous system and internal environment
• violation of the myelination process, the development of neuropathy
• the development of oxidative stress
• neurodegenerative processes in the central nervous system.
It is extremely difficult to establish a cause-effect relationship between various factors affect-
ing the development of iron deficiency, neurocognitive impairment, and comorbid condi-
tions [2, 11, 20, 36]. For example, it has yet to determine the diagnostic significance of the 
mutations responsible for the development of severe and/or refractory forms of IDA. Genetic 
Figure 5. Components of iron homeostasis affecting human neurocognitive development.
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causes can involve quantitative or qualitative impairment of globin chain synthesis (thalas-
semia and sickle cell disease, respectively) [169], or genetically related abnormalities of the 
erythrocyte, either at the membrane level (pyruvate kinase, glucose-6-phosphate dehydro-
genase (G6PD), and stomatocytosis) or concerning enzyme function (hereditary spherocyto-
sis also known as Minkowski-Chauffard syndrome). In addition, a number of rare anemias 
are related to genetic defects of iron metabolism itself. These defects involve mutations of 
genes that play a role in systemic or cellular iron metabolism [170]. Despite the relatively 
low prevalence of iron deficiency in high-income countries using current diagnostic crite-
ria in this healthy cohort, microcytosis was associated with lower cognitive outcomes after 
2 years. This research study emphasizes the need to reassess the diagnostic criteria for iron 
deficiency in young children, while further research is required in studies with adequate 
nutrition [171].
The metabolic ring of iron homeostasis demonstrates the involvement of a large number 
of components. However, the establishment of cause-effect relationships is difficult due to 
differentiate in interpreting the pathogenesis of IDA and cognitive disorders, because of 
which it is impossible to talk about unidirectional processes in the homeostatic ring of iron 
(Figure 5).
In elderly adults, the cause of cognitive impairment is often vascular lesions of the brain, 
which can be combined with an imbalance of essential trace elements. Over time, a person 
begins to show violations of daily behavior due to disruptions in the work of cognitive func-
tions. In children, we need to look mostly for perinatal and post-natal events. So, compre-
hensive mechanism of the development cognitive dysfunctions in children and elder people 
needs different protocols for the treatment of ID and IDA.
Difficulties in studying the influence of ID on the level of IQ, individual manifestations of 
neurocognitive insufficiency, are because they often have a latent character, and in the case of 
their diagnosis, there are serious problems in deciphering etiology mechanisms and organiz-
ing optimal therapy.
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